Anti-TPBG (clone A1)-VC-MMAE ADC
This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a VC linker to MMAE. The MMAE is targeted to TPBG-positive cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![[1 (1S) ]-2,3:4,5-Di-O-cyclohexylidene-6-O- (phenylmethyl) -D-myo-Inositol 4,7,7-Trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
411576 25 mg
[1 (1S) ]-2,3:4,5-Di-O-cyclohexylidene-6-O- (phenylmethyl) -D-myo-Inositol 4,7,7-Trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate
Ask
View Details GTR15179481 1 Vial
Lentiviral mouse Acvr1c shRNA (UAS) - Lentiviral mouse Acvr1c shRNA (UAS, GFP) (100)
Ask
View Details 